Connect with us
Merck is acquiring Mirus Bio for $600 million to accelerate growth in revolutionary technologies. CEO Belén Garijo aims to make cell and gene therapies accessible globally....
Merck invests over 300 million euros in a new biotech research center in Germany, part of a larger 1.5 billion euro investment program for Darmstadt. The...
With stiff competition from established medical companies and the stigma linked to marijuana, the challenges are real.
Keytruda, a cancer drug developed by Merck & Co, was able to notably shrink the tumors of 48 out of 88 patients. Another 18 saw their...